By Timo Minssen Following a request by the European Competition Law Review (Sweet Maxwell), I have today submitted a review of the recent publication “Pharmaceutical Innovation, Competition and Patent Law – A Trilateral Perspective”, edited by Max Planck Director Josef Drexl and Finnish scholar Nari Lee (Edward Elgar 2013, 322 p., ISBN 978 0 85793…
By Kuei-Jung Ni I am pleased to post that my new book, “Science and Technology in International Economic Law: Balancing Competing Interests” (co-edited with Professor Bryan Mercurio at the Chinese University of Hong Kong), was recently published by Routledge. In addition to the introduction, the book includes thirteen articles written by scholars from the Asia-Pacific…
By The Petrie-Flom Center On November 21, the Petrie-Flom Center hosted a lecture by Neil Flanzraich on responsible pricing strategy, access to care, clinical trial design, outsourcing, and other topics that raise thorny but crucial issues for pharmaceutical and biotechnology companies. (You can read a summary of the lecture here.) You can now view the lecture online.…
By Nicholson Price Antibiotics are a crucial aspect of modern medicine, and this fall has been filled with a number of hugely troubling reports about how we’re moving closer to an era where we can no longer take them for granted. About a month ago, the associate director of the CDC told PBS in an…
By Leslie Francis At the University of Utah, our Center on Law and Biomedical Sciences was fortunate to be able to hold a recent symposium on the future of gene patenting. Our speakers included Ken Chahine and Amelia Rinehart, both faculty at the College of Law, presenting accounts of the science and patent law; Brian…
For more information, visit the STS website.
By Aditya Gupta By a detailed order passed last week, the Indian Patent Office rejected an application for compulsory license filed by a generic drug manufacturer BDR Pharmaceuticals International Pvt. Ltd. (“BDR”) seeking a license of Bristol Myers Squibb’s (“BMS”) Indian patent for an anti-cancer drug. The Indian Patent Office found that BDR had not made out…
For more information, visit the STS website.
By The Petrie-Flom Center [Ed. Note: This report stems from the “Issues in Clinical Data Sharing Conference” co-sponsored by MRCT and Petrie-Flom last May.] Press Release: A new report by researchers from Harvard University and others in a working group convened by the Multi-Regional Clinical Trials Center (MRCT) at Harvard proposes recommendations for addressing a problem that…
For more information, visit the STS website.
